|
|
Volumn 374, Issue 7, 2016, Pages 684-686
|
|
Epigenetic modulators and the new immunotherapies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZACITIDINE;
DNA METHYLTRANSFERASE INHIBITOR;
DOUBLE STRANDED RNA;
IMMUNOMODULATING AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DNA (CYTOSINE 5) METHYLTRANSFERASE;
ENZYME INHIBITOR;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
DNA METHYLATION;
EPIGENETICS;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOREGULATION;
MELANOMA;
NONHUMAN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROMOTER REGION;
SIGNAL TRANSDUCTION;
UPREGULATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
GENE EXPRESSION;
GENETIC EPIGENESIS;
GENETICS;
IMMUNOLOGY;
IMMUNOTHERAPY;
MOUSE;
NEOPLASM;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
AZACITIDINE;
DNA (CYTOSINE-5-)-METHYLTRANSFERASE;
DNA METHYLATION;
ENZYME INHIBITORS;
EPIGENESIS, GENETIC;
GENE EXPRESSION;
HUMANS;
IMMUNOTHERAPY;
MICE;
NEOPLASMS;
|
|
EID: 84959019222
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr1514673 Document Type: Article |
|
Times cited : (47)
|
|
References (5)
|
